Astria Therapeutics Inc
NASDAQ:ATXS

Watchlist Manager
Astria Therapeutics Inc Logo
Astria Therapeutics Inc
NASDAQ:ATXS
Watchlist
Price: 12.51 USD -1.65% Market Closed
Market Cap: 714.1m USD

Intrinsic Value

The intrinsic value of one ATXS stock under the Base Case scenario is hidden USD. Compared to the current market price of 12.51 USD, Astria Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

ATXS Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Astria Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

ATXS looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether ATXS usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about ATXS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ATXS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Astria Therapeutics Inc.

Explain Valuation
Compare ATXS to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ATXS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Astria Therapeutics Inc

Current Assets 253.5m
Cash & Short-Term Investments 227.7m
Receivables 17.2m
Other Current Assets 8.6m
Non-Current Assets 18.3m
PP&E 4.3m
Other Non-Current Assets 14.1m
Current Liabilities 23.5m
Accounts Payable 1.1m
Accrued Liabilities 17.9m
Other Current Liabilities 4.5m
Non-Current Liabilities 15.1m
Other Non-Current Liabilities 15.1m
Efficiency

Free Cash Flow Analysis
Astria Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Astria Therapeutics Inc

Revenue
706k USD
Operating Expenses
-137.2m USD
Operating Income
-136.5m USD
Other Expenses
12.5m USD
Net Income
-124m USD
Fundamental Scores

ATXS Profitability Score
Profitability Due Diligence

Astria Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Astria Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ATXS Solvency Score
Solvency Due Diligence

Astria Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
hidden
Solvency
Score

Astria Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ATXS Price Targets Summary
Astria Therapeutics Inc

Wall Street analysts forecast ATXS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATXS is 21.62 USD with a low forecast of 13.13 USD and a high forecast of 36.75 USD.

Lowest
Price Target
13.13 USD
5% Upside
Average
Price Target
21.62 USD
73% Upside
Highest
Price Target
36.75 USD
194% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Astria Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ATXS is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ATXS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ATXS stock?

The intrinsic value of one ATXS stock under the Base Case scenario is hidden USD.

Is ATXS stock undervalued or overvalued?

Compared to the current market price of 12.51 USD, Astria Therapeutics Inc is hidden .

Back to Top